We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Lumenis Plagued with Problems

By HospiMedica staff writers
Posted on 07 Jan 2003
As a result of a string of financial and other problems, Lumenis Ltd. More...
(Yokneam, Israel) has announced that its CEO, Yacha Sutton, has retired. The board has formed a search committee to find a permanent CEO. In the meantime, the company's vice chairman has assumed CEO duties.

Lumenis, a leading global supplier of medical lasers, is being investigated by the US Securities and Exchange Commission (SEC), which is questioning the veracity of its financial statements, and has been sued by a former financial officer who charged he was terminated in retaliation for disclosing accounting irregularities. Nonetheless, the principal lender to Lumenis, Bank Hapoalim, has confirmed its continued support of the company.

Lumenis has become the world leader in the surgical CO2 market. The company was formed in April 2001 when ESC Medical Systems and Coherent Medical Group joined forces. Both were pioneers in the application of light to medical and esthetic procedures. Three years earlier, ESC had acquired Laser Industries, with its well-known Sharplan brand name. Recently, Lumenis introduced the UltraPulse SurgiTouch as the first "smart” laser. It is based on the CO2 laser technology of Coherent and the advanced scanning capability of the ESC Sharplan SurgiTouch.

Still, sales have not met the company's expectations. In announcing third quarter results in October 2002, CEO Sutton said, "Lower US esthetic sales and an adverse product mix impacted margins in the third quarter. Operating expenses, while reduced from previous levels due to our cost reduction program, were adversely affected by the costs associated with the gathering of documents and other information in connection with the SEC investigation.”


Related Links:
Lumenis

Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Gas Analyzer
i-Check200
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.